| Literature DB >> 16571106 |
Ken Stein1, Julie Ratcliffe, Ali Round, Ruairidh Milne, John E Brazier.
Abstract
BACKGROUND: The completeness of preferences is assumed as one of the axioms of expected utility theory but has been subject to little empirical study.Entities:
Mesh:
Year: 2006 PMID: 16571106 PMCID: PMC1440847 DOI: 10.1186/1477-7525-4-22
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.186
Panel characteristics
| Sex | Male | 9 (60) |
| Female | 5 (40) | |
| Marital status | Married | 13 (87) |
| Widowed | 2 (13) | |
| Occupation | Retired | 8 (53) |
| Working part-time | 7 (47) | |
| Level of educational attainment | Higher degree (MSc, PhD etc.) | 7 (47) |
| First Degree (BSc etc.) | 2 (13) | |
| NVQ Level 4–5, HNC, HND | 2 (13) | |
| 2 or more A' Levels | 2 (13) | |
| Other qualifications | 1 (7) | |
| Data missing | 1 (7) | |
| Ethnicity | White | 15 (100) |
Summary preference values before and after discussion
| Mean (SD) | Median (range) | Mean (SD) | Median (range) | Mean (SD) | Median | ||
| 1. | Multiple sclerosis state 1 | 0.75 (0.21) | 0.85 (0.48–1.0) | 0.83 (0.16) | 0.88 (0.48–1.0) | 0.08 (-0.01) | 0.03 |
| 2. | Multiple sclerosis state 2 | 0.94 (0.06) | 0.98 (0.85–1.0) | 0.93 (0.05) | 0.93 (0.85–1.0) | -0.01 (-0.05) | -0.05 |
| 3. | Gaucher's disease | 0.88 (0.14) | 0.93 (0.5–1.0) | 0.88 (0.14) | 0.93 (0.5–1.0) | 0 (0) | 0 |
| 4. | EQ5D state 1 | 0.97 (0.03) | 0.98 (0.9–1.0) | 0.98 (0.02) | 0.98 (0.93–1.0) | 0.01 (-0.01) | 0 |
| 5. | EQ5D state 2 | 0.3 (0.51) | 0.48 (-0.88–0.88) | 0.30 (0.51) | 0.48 (-0.88–0.88) | 0 (0) | 0 |
| 6. | EQ5D state 3 | 0.75 (0.19) | 0.83 (0.38–0.98) | 0.75 (0.20) | 0.83 (0.38–0.98) | 0 (0.01) | 0 |
| 7. | Heart failure state 1 | 0.84 (0.26) | 0.93 (0.05–0.98) | 0.84 (0.26) | 0.93 (0.05–0.98) | 0 (0) | 0 |
| 8. | Heart failure state 2 | 0.51 (0.42) | 0.56 (-0.68–0.93) | 0.50 (0.41) | 0.56 (-0.68–0.93) | -0.01 (-0.01) | 0 |
| 9. | Moderate eczema | 0.782 (0.22) | 0.88 (0.28–1.0) | 0.786 (0.22) | 0.88 (0.28–1.0) | 0.004 (0) | 0 |
| 10. | Severe eczema | 0.70 (0.23) | 0.68 (0.3–1.0) | 0.69 (0.21) | 0.68 (0.3–0.95) | -0.01 (-0.02) | 0 |
| 11. | Osteoarthritis state 1 | 0.96 (0.06) | 1.00 (0.83–1.0) | 0.96 (0.06) | 0.98 (0.83–1.0) | 0 (0) | -0.02 |
| 12. | Osteoarthritis state 2 | 0.83 (0.13) | 0.83 (0.58–1.0) | 0.83 (0.11) | 0.83 (0.68–1.0) | 0 (-0.02) | 0 |
| 13. | Osteoarthritis state 3 | 0.96 (0.04) | 0.98 (0.88–1.0) | 0.97 (0.03) | 0.98 (0.93–1.0) | 0.01 (-0.01) | 0 |
| 14. | Osteoarthritis state 4 | 0.98 (0.02) | 0.98 (0.93–1.0) | 0.98 (0.02) | 0.99 (0.93–1.0) | 0 (0) | 0.01 (0) |
Individual changes made to preferences after discussion
| A | 25 | 2 (8.0) | -0.125, 0.05 |
| B | 30 | 2 (6.7) | 0.05, 0.025 |
| C | 41 | 2 (4.9) | 0.45, -0.075 |
| D | 16 | 1 (6.3) | 0.2 |
| E | 35 | 3 (8.6) | -0.025, 0.1, 0.05 |
| F | 34 | 1 (2.9) | -0.05 |
| G | 26 | 5 (19.2) | -0.025, 0.075, 0.025, -0.1, 0.05 |